Lianluo Smart (Lianluo Smart) Debt-to-Asset : 0.30 (As of Dec. 2020)

View and export this data going back to 2010. Start your Free Trial

What is Lianluo Smart Debt-to-Asset?

Lianluo Smart's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was $1.78 Mil. Lianluo Smart's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was $0.00 Mil. Lianluo Smart's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2020 was $6.05 Mil. Lianluo Smart's debt to asset for the quarter that ended in Dec. 2020 was 0.29.

Lianluo Smart Debt-to-Asset Historical Data

The historical data trend for Lianluo Smart's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lianluo Smart Debt-to-Asset Chart

Lianluo Smart Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Debt-to-Asset

Get a 7-Day Free Trial

0.10

0.52

0.30

Lianluo Smart Semi-Annual Data
	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Debt-to-Asset	Get a 7-Day Free Trial															-	0.21	0.52	0.25	0.30

Competitive Comparison of Lianluo Smart's Debt-to-Asset

For the Medical Devices subindustry, Lianluo Smart's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lianluo Smart's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lianluo Smart's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Lianluo Smart's Debt-to-Asset falls into.

Lianluo Smart Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Lianluo Smart's Debt-to-Asset for the fiscal year that ended in Dec. 2020 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.784	+	0)	/	6.048
	=	0.29

Lianluo Smart's Debt-to-Asset for the quarter that ended in Dec. 2020 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.784	+	0)	/	6.048
	=	0.29

Lianluo Smart (NAS:LLIT) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Lianluo Smart Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Lianluo Smart's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Lianluo Smart (Lianluo Smart) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lianluo Smart Ltd (NAS:LLIT) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 10 Baifuquan Roa, Room 611, 6th Floor, BeiKong Technology Building, Changping District, Beijing, CHN, 102200

Website

http://www.lianluosmart.com

Lianluo Smart Ltd design, develop and market medical products and medical components. The company focuses on the business sectors of; Medical Equipment and the provision of Obstructive Sleep Apnea Syndrome (OSAS) diagnostic services. Its products include wearable sleep respiratory devices, medical devices for cardiopulmonary resuscitation, DHR998 Plus, and others. The company sells its products to distributors, hospitals and physical examination centers, and others. All of its revenue is generated from China.